Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Rekombinanter SARS-CoV-2 Spike Antikörper (AA 319-541)

Dieses Anti-SARS-CoV-2 Spike-Antikörper ist ein Maus Monoklonal-Antikörper zur Detektion von SARS-CoV-2 Spike in ELISA, WB, FACS und IF. Geeignet für SARS Coronavirus-2 (SARS-CoV-2).
Produktnummer ABIN7581775

Kurzübersicht für Rekombinanter SARS-CoV-2 Spike Antikörper (AA 319-541) (ABIN7581775)

Target

Alle SARS-CoV-2 Spike Antikörper anzeigen
SARS-CoV-2 Spike

Antikörpertyp

Recombinant Antibody

Reaktivität

  • 120
  • 7
  • 3
  • 2
  • 2
  • 2
  • 1
  • 1
SARS Coronavirus-2 (SARS-CoV-2)

Wirt

  • 54
  • 31
  • 30
  • 3
  • 2
  • 2
  • 1
  • 1
Maus

Klonalität

  • 92
  • 18
  • 11
Monoklonal

Konjugat

  • 98
  • 18
  • 3
  • 1
  • 1
Dieser SARS-CoV-2 Spike Antikörper ist unkonjugiert

Applikation

  • 100
  • 53
  • 25
  • 13
  • 9
  • 7
  • 4
  • 3
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
ELISA, Western Blotting (WB), Flow Cytometry (FACS), Immunofluorescence (IF)

Güteklasse

Animal-Free

Klon

AB68-A09
  • Bindungsspezifität

    • 64
    • 11
    • 4
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 319-541

    Expressionssystem

    Phage display

    Verwendungszweck

    recombinant anti-SARS-CoV-2 spike antibody

    Spezifität

    This is an antibody developed by antibody phage display technology using a human naive antibody gene library and SARS-CoV-2 antigen. For this antibody both the heavy and light chains are cloned and expressed, generating full-length antibodies.

    Kreuzreaktivität (Details)

    No known cross reactivity. No cross-reactivity to other human coronaviruses.

    Produktmerkmale

    This antibody can be detected with anti-mouse Fc secondary antibodies.

    Aufreinigung

    Protein A purification

    Immunogen

    No immunization, animal-free antibody development. Antigen: Spike Protein SARS-CoV2 RVQPTESIVRFPNITNLCPFGEVFNATRFASVYAWNRKRISNCVADYSVLYNSASFSTFKCYGVSPTKLNDLCFTNVYADSFVIRGDEVRQIAPGQTGKIADYNYKLPDDFTGCVIAWNSNNLDSKVGGNYNYLYRLFRKSNLKPFERDISTEIYQAGSTPCNGVEGFNCYFPLQSYGFQPTNGVGYQPYRVVVLSFELLHAPATVCGPKKSTNLVKNKCVNF

    Isotyp

    IgG2a
  • Applikationshinweise

    Western Blot: 0.2-5 μg/mL ELISA: 1-12 μg/mL as coating antibody 0.5-5 μg/mL as detection antibody IF: 0.1 - 10 μg/mL Optimal working dilution should be determined by the investigator

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Liquid

    Konzentration

    1 mg/mL

    Buffer

    PBS, pH 7.4,

    Lagerung

    -20 °C
  • Target

    SARS-CoV-2 Spike

    Andere Bezeichnung

    SARS-CoV-2 spike protein (RBD)

    Hintergrund

    Coronaviruses (CoVs) are enveloped non-segmented positive-sense single-stranded RNA viruses and can infect respiratory, gastrointestinal, hepatic and central nervous system of human and many other wild animals. Recently, a new severe acute respiratory syndrome β-coronavirus called SARS-CoV-2 (or 2019-nCoV) has emerged, which causes an epidemic of acute respiratory syndrome (called coronavirus human disease 2019 or COVID-19). SARS-CoV-2 shares 79.5 % sequence identity with SARS-CoV and is 96.2 % identical at the genome level to the bat coronavirus BatCoV RaTG133, suggesting it had originated in bats. SARS-CoV-2 contains 4 structural proteins, including Envelope (E), Membrane (M), Nucleocapsid (N) and Spike (S), which is a transmembrane protein, composed of two subunits S1 and S2. The S protein plays a key role in viral infection and pathogenesis. The S1 subunit contains the N-terminal domain (NTD) and a receptor binding domain (RBD), which binds to the cell surface receptor Angiotensin-Converting Enzyme 2 (ACE2) present at the surface of epithelial cells, causing mainly infection of human respiratory cells, whereas S2 harbors heptad repeat 1 (HR1) and HR2. The RBD domain first binds its receptor to form an RBD/ACE2 complex. This triggers conformational changes in the S protein, leading to membrane fusion mediated via HR1 and HR2 and consequently in viral entry into target cells. Antibodies targeting various regions of S protein have different mechanisms in inhibiting SARS-CoV-2 infection. For example, NTD-targeting antibodies bind the NTD to form an NTD/mAb complex, thereby preventing conformational changes in the S protein and blocking membrane fusion and viral entry. RBD-targeting antibodies form RBD/mAb or RBD/Nb complexes that could inhibit binding of the RBD to ACE2, thereby preventing entry of SARS-CoV-2 into target cells.

    Molekulargewicht

    76 kDa

    NCBI Accession

    YP_009724390

    UniProt

    P0DTC2
Sie sind hier:
Chat with us!